Researchers at Janssen Pharmaceutical Companies of Johnson & Johnson in Leiden have developed a small molecule...
Up To Date
Latest News
Seventure Partners has announced the first close of its second microbiome fund designed to put €200m in 20...
Swiss immunology and immuno-oncology specialist Numab Innovation AG has licenced its tri-specific antibody...
Biogen has strengthened its portfolio with Nightstar Therapeutics, a British gene therapy specialist for rare...
Share
